Clinical Trials Browser

OTHER × Pancreatic Neoplasms × dapagliflozin × Clear all

NCT04542291 2023-02-14

Targeting Pancreatic Cancer With Sodium Glucose Transporter 2 (SGLT2) Inhibition

Phase 1 Completed

15 enrolled 15 charts

Gastrointestinal

Pancreatic Neoplasms